Amgen pilots new drug strategy after investing in T.O. campus

You are here: Home > middle > Current Article

Amgen pilots new drug strategy after investing in T.O. campus

By Marissa Nall / Friday, September 7th, 2018 / Comments Off on Amgen pilots new drug strategy after investing in T.O. campus

Some employees have new work spaces after Amgen spent $200 million renovating and upgrading its Thousand Oaks campus. (Marissa Nall photo)   Investments at its flagship facilities in Thousand Oaks mark a strategic shift for Amgen when it comes to choosing which diseases the biotech giant tackles. With the infusion of $200 million in capital,…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.